Modeling Principle

The hTNFα-Tg Mouse Spontaneous Arthritis Model is a SCI gold-standard transgenic animal model in the fields of rheumatoid arthritis (RA) mechanism research, chronic autoimmune joint inflammation, pathological synovial hyperplasia, articular osteochondral erosion, and TNF-α targeted drug research and development. This model stably overexpresses human tumor necrosis factor-α (hTNF-α) through gene editing technology. It does not require exogenous antigen induction or artificial modeling intervention, and can develop spontaneous and progressive symmetrical multi-joint inflammatory lesions with increasing age, which highly recapitulates the core pathological process and clinical phenotypes of human rheumatoid arthritis. The model can completely reproduce the key characteristics of clinical RA onset: abnormal hyperplasia of synovial lining layer, continuous inflammatory cell infiltration, chronic intra-articular inflammatory exudation, pannus neogenesis, degenerative cartilage damage and progressive bone erosion, perfectly simulating the chronic, recurrent and progressively aggravated characteristics of clinical autoimmune joint lesions. Compared with artificially induced arthritis models such as adjuvant-induced and collagen-induced models, the hTNFα-Tg mouse model has the core advantages of spontaneous onset, stable disease course, persistent inflammation, uniform phenotype and no artificial intervention error. The inflammatory pathway is centered on the classic TNF-α-mediated chronic immune inflammatory axis, and the pathological mechanism is highly homologous with human clinical RA, with extremely low data dispersion and excellent reproducibility. Its experimental paradigm fully meets the standardized specifications of high-impact SCI journals in rheumatology, orthopedics, biomaterials and targeted pharmacology, National Natural Science Foundation projects, and postgraduate research proposals and dissertations, serving as the optimal standardized transgenic model for basic mechanism research and preclinical targeted drug screening of chronic rheumatoid arthritis.

Modeling Success Criteria

Quantitative Clinical Phenotype and Physical Sign Criteria

Unified model evaluation is completed at the experimental endpoint of 24 weeks old, and there are significant statistical differences between the model group and wild-type control group: 1. Joint physical signs: mice in the model group present symmetrical redness, swelling and deformity of distal limb joints, increased joint skin temperature, swollen and deformed joint contours, and joint stiffness during movement; 2. Behavioral phenotype: mice show typical arthritis dysfunction manifestations such as abnormal gait, claudication, uneven limb weight bearing, decreased activity and limited limb flexion and extension; 3. Quantitative scoring: the clinical arthritis score and joint swelling degree of the model group are significantly higher than those of the wild-type control group with statistically significant inter-group differences; 4. Disease course stability: no spontaneous remission, sudden death or unilateral occasional lesions, presenting a stable, continuous and symmetrical chronic inflammatory disease course without invalid model individuals. The spontaneous rheumatoid arthritis model is successfully established when the above physical sign and functional indicators reach the standard.

Histomorphometric Gold-Standard Indexes

Gold-standard histopathological evaluation of joint synovium and osteochondral tissues: the model group shows significant proliferation and thickening of synovial tissue, disordered synovial structure, continuous infiltration of a large number of inflammatory cells, and obvious intra-articular inflammatory exudation; a large number of pannus neogenesis invade the joint space and erode the superficial cartilage; cartilage matrix loss, thinning and disordered arrangement of cartilage layer occur with typical degenerative cartilage lesions; cortical bone presents bone resorption, bone erosion, trabecular disorder and other osseous damage. The wild-type control group has complete synovial structure, clear layers, no obvious inflammatory infiltration, and intact cartilage and bone tissues. Core histomorphometric indexes: the synovial hyperplasia thickness, inflammatory infiltration area ratio, pannus neogenesis number, cartilage damage score and bone erosion degree of the model group are significantly higher than those of the control group. The pathological phenotype is completely consistent with the characteristics of human chronic rheumatoid arthritis, meeting the SCI gold standard for academic credibility.

Academic Evidence for Model Validity

The core academic validity basis of this model is as follows: stable overexpression of human hTNF-α gene continuously activates the classic TNF-α/NF-κB autoimmune inflammatory pathway, inducing a cascade pathological reaction of chronic persistent synovial inflammation-pannus formation-cartilage degeneration-bone erosion, which completely recapitulates the autoimmune pathogenesis and chronic progressive course of clinical rheumatoid arthritis. Without artificial induction, the model has spontaneous and stable disease onset, minimal individual differences and highly unified disease course sequence, which can accurately distinguish the inhibitory and repair efficacy of different interventions on chronic joint inflammation, synovial hyperplasia and osteochondral damage. It is currently the most clinically compatible, highly reproducible and clearly defined transgenic RA gold-standard model in the field of rheumatology and immunology.

Model Advantages

The hTNFα-Tg Mouse Spontaneous Arthritis Model is a top-tier SCI gold-standard transgenic model in the fields of rheumatoid arthritis basic mechanism, chronic autoimmune inflammation, osteochondral damage mechanism and anti-RA targeted drug research and development. The pathogenesis is completely anchored to the clinical core pathogenic TNF-α pathway, and the pathological process and tissue damage phenotype are highly homologous with human RA, with significantly better clinical translational value than artificially induced models. It has completely spontaneous disease onset without exogenous interference caused by artificial puncture, antigen immunity and drug induction, with pure experimental baseline and extremely high data credibility. It has strong progressive disease course, stable time sequence, minimal individual differences and the best recognized reproducibility in the industry. It can completely simulate the complete pathological chain of continuous activation of chronic inflammation, synovial hyperplasia, pannus invasion and progressive osteochondral destruction. It adapts to long-term intervention, multi-time-point dynamic observation and multi-dimensional index closed-loop verification. The experimental conclusions are highly recognized and easily accepted by top journals in rheumatology, translational medicine, pharmacology and orthopedics, fully adapting to the high-level scientific research system of National Natural Science Foundation projects, fund application, research proposals and postgraduate dissertations.

Research Applications

This model is mainly used to systematically elucidate the core molecular mechanisms of TNF-α-mediated chronic autoimmune inflammation, pathological synovial hyperplasia, pannus formation, osteochondral degeneration and bone erosion. It accurately evaluates the inhibitory effect and joint protection efficacy of novel targeted drugs, natural active ingredients, traditional Chinese medicine compounds, biological agents and anti-inflammatory materials on chronic inflammation of rheumatoid arthritis. It verifies the linkage regulation mechanism of inflammation-synovial hyperplasia-bone metabolism disorder and explores novel RA intervention targets and immune regulation pathways, optimizing long-term intervention schemes and administration strategies for chronic arthritis. It is widely applied in high-level scientific research scenarios including basic mechanism research of rheumatoid arthritis, preclinical evaluation of new targeted drugs, translational medicine research of rheumatology and immunology, fund project application, research proposal writing and high-impact SCI paper publication, serving as an irreplaceable standardized transgenic gold-standard model in the RA field.

hTNFα-Tg mouse，spontaneous arthritis，rheumatoid arthritis model，chronic inflammation，synovial hyperplasia，joint erosion，autoimmune arthritis，TNF-α pathway，rheumatological immune model，anti-inflammatory targeted drug screening